Switching from baricitinib to dupilumab as an advanced-line treatment in pediatric patients with atopic dermatitis: a retrospective cohort study

Ayelet Ollech, Eran Cohen-Barak, Amir Horev, Efrat Bar-Ilan, Shoshana Greenberger

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)e130-e132
JournalInternational Journal of Dermatology
Volume63
Issue number7
DOIs
StatePublished - Jul 2024
Externally publishedYes

Keywords

  • atopic dermatitis
  • biological treatment
  • dupilumab baricitinib
  • JAK inhibitors
  • pediatric patients
  • systemic treatment
  • Severity of Illness Index
  • Humans
  • Child, Preschool
  • Male
  • Pyrazoles/administration & dosage
  • Treatment Outcome
  • Purines/administration & dosage
  • Dermatitis, Atopic/drug therapy
  • Dermatologic Agents/therapeutic use
  • Sulfonamides/therapeutic use
  • Antibodies, Monoclonal, Humanized/administration & dosage
  • Adolescent
  • Female
  • Retrospective Studies
  • Azetidines/therapeutic use
  • Drug Substitution
  • Child

ASJC Scopus subject areas

  • Dermatology

Cite this